Original research article: Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction

DOI: 10.1136/openhrt-2017-000765

Keywords: PCSK9, acute coronary syndrome, anti-IL6 therapy, inflammation

Full-Text   Cite this paper   Add to My Lib

Abstract:

It is unclear if activation of inflammatory pathways regulates proprotein convertase subtilisin-kexin type 9 (PCSK9) levels

Full-Text